Ashraf Badros
University of Maryland, Baltimore(US)University of Maryland Medical Center(US)Green Chemistry(PL)Sidney Kimmel Comprehensive Cancer Center(US)U-M Rogel Cancer CenterU-M Rogel Cancer Center(US)University of Baltimore(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma(2015)835 cited
- → Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study(2019)777 cited
- → Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study(2011)720 cited
- → Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors(2006)595 cited
- → Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy(2001)496 cited
- → Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement(2015)390 cited